{"title":"《柳叶刀呼吸医学2025》修正;7月10日在网上发表。https://doi.org/10.1016/s2213 00125 - 0 - 2600 (25)","authors":"","doi":"10.1016/s2213-2600(25)00295-4","DOIUrl":null,"url":null,"abstract":"<em>Lemiale V, Resche-Rigon M, Zerbib Y, et al. Adjunctive corticosteroids in non-AIDS patients with severe Pneumocystis jirovecii pneumonia (PIC): a multicentre, double-blind, randomised controlled trial.</em> Lancet Respir Med <em>2025; published online July 10. https://doi.org/10.1016/S2213-2600(25)00125-0</em>—In this Article, the seventh sentence of the fifth paragraph in the Statistical analysis section should have read “Ventilatory-free days at day 28 was calculated as ventilatory free days = 28 – x, if successfully liberated from ventilation x days after initiation…”. This correction has been made to the online version as of August 1, 2025, and will be made to the printed version.","PeriodicalId":51307,"journal":{"name":"Lancet Respiratory Medicine","volume":"27 1","pages":""},"PeriodicalIF":32.8000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Correction to Lancet Respir Med 2025; published online July 10. https://doi.org/10.1016/S2213-2600(25)00125-0\",\"authors\":\"\",\"doi\":\"10.1016/s2213-2600(25)00295-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<em>Lemiale V, Resche-Rigon M, Zerbib Y, et al. Adjunctive corticosteroids in non-AIDS patients with severe Pneumocystis jirovecii pneumonia (PIC): a multicentre, double-blind, randomised controlled trial.</em> Lancet Respir Med <em>2025; published online July 10. https://doi.org/10.1016/S2213-2600(25)00125-0</em>—In this Article, the seventh sentence of the fifth paragraph in the Statistical analysis section should have read “Ventilatory-free days at day 28 was calculated as ventilatory free days = 28 – x, if successfully liberated from ventilation x days after initiation…”. This correction has been made to the online version as of August 1, 2025, and will be made to the printed version.\",\"PeriodicalId\":51307,\"journal\":{\"name\":\"Lancet Respiratory Medicine\",\"volume\":\"27 1\",\"pages\":\"\"},\"PeriodicalIF\":32.8000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lancet Respiratory Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/s2213-2600(25)00295-4\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CRITICAL CARE MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Respiratory Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/s2213-2600(25)00295-4","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
Correction to Lancet Respir Med 2025; published online July 10. https://doi.org/10.1016/S2213-2600(25)00125-0
Lemiale V, Resche-Rigon M, Zerbib Y, et al. Adjunctive corticosteroids in non-AIDS patients with severe Pneumocystis jirovecii pneumonia (PIC): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med 2025; published online July 10. https://doi.org/10.1016/S2213-2600(25)00125-0—In this Article, the seventh sentence of the fifth paragraph in the Statistical analysis section should have read “Ventilatory-free days at day 28 was calculated as ventilatory free days = 28 – x, if successfully liberated from ventilation x days after initiation…”. This correction has been made to the online version as of August 1, 2025, and will be made to the printed version.
期刊介绍:
The Lancet Respiratory Medicine is a renowned journal specializing in respiratory medicine and critical care. Our publication features original research that aims to advocate for change or shed light on clinical practices in the field. Additionally, we provide informative reviews on various topics related to respiratory medicine and critical care, ensuring a comprehensive coverage of the subject.
The journal covers a wide range of topics including but not limited to asthma, acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), tobacco control, intensive care medicine, lung cancer, cystic fibrosis, pneumonia, sarcoidosis, sepsis, mesothelioma, sleep medicine, thoracic and reconstructive surgery, tuberculosis, palliative medicine, influenza, pulmonary hypertension, pulmonary vascular disease, and respiratory infections. By encompassing such a broad spectrum of subjects, we strive to address the diverse needs and interests of our readership.